Yokoyama M, Suwa A, Shinozawa T, Fujii T, Mimori T, Akizuki M, Ichikawa Y, Tojo T
Department of Internal Medicine, Keio University School of Medicine.
Nihon Rinsho Meneki Gakkai Kaishi. 1995 Apr;18(2):207-14. doi: 10.2177/jsci.18.207.
A 71 year-old man with adult onset Still's disease was admitted to our hospital because of fever, sore throat, myalgia and macular nonpruritic salmon pink eruption. He was treated with prednisolone, 40 mg daily and these symptoms disappeared. When the dose of prednisolone was reduced to 30 mg daily, he began to notice fever. 5 days later he developed adult respiratory distress syndrome (ARDS). The dose of prednisolone was increased to 50 mg daily and oxygen administration was started. All symptoms began to improve immediately and the dose of prednisolone was decreased to 40 mg daily. 10 days later he noticed fever and skin rash. Laboratory investigation showed platelet counts of 69,000/mm3, a ferritin of 37,000 ng/ml, and increased fibrinogen degradation product, indicating increased activity of adult onset Still's disease associated with disseminated intravascular coagulation (DIC). The dose of prednisolone was again increased to 60 mg daily, and 100 mg of nafamostat mesilate was administrated intravenously. All above symptoms associated with adult onset Still's disease and DIC disappeared. The dose of prednisolone was gradually decreased and the clinical course was uneventful with daily administration of 10 mg of prednisolone. Although there are a couple of case report which described the association of adult onset Still's disease with either ARDS or DIC, the association of adult onset Still's disease with both ARDS and DIC have not been reported yet.
一名患有成人斯蒂尔病的71岁男性因发热、咽痛、肌痛和非瘙痒性斑丘疹样鲑鱼粉红色皮疹入住我院。他接受了每日40毫克泼尼松龙的治疗,这些症状消失。当泼尼松龙剂量减至每日30毫克时,他开始出现发热。5天后,他发展为成人呼吸窘迫综合征(ARDS)。泼尼松龙剂量增至每日50毫克,并开始吸氧。所有症状立即开始改善,泼尼松龙剂量减至每日40毫克。10天后,他又出现发热和皮疹。实验室检查显示血小板计数为69,000/mm³,铁蛋白为37,000 ng/ml,纤维蛋白原降解产物增加,提示成人斯蒂尔病活动增加并伴有弥散性血管内凝血(DIC)。泼尼松龙剂量再次增至每日60毫克,并静脉注射100毫克甲磺酸萘莫司他。所有与成人斯蒂尔病和DIC相关的上述症状均消失。泼尼松龙剂量逐渐减少,每日服用10毫克泼尼松龙时临床过程平稳。虽然有几例病例报告描述了成人斯蒂尔病与ARDS或DIC的关联,但成人斯蒂尔病与ARDS和DIC两者的关联尚未见报道。